# Time To Efficacy and Onset Of Action Of Linezolid

> **NCT00147511** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 118 (actual)

## Conditions studied

- Gram-Positive Bacterial Infections
- Skin and Connective Tissue Diseases

## Interventions

- **DRUG:** linezolid

## Key facts

- **NCT ID:** NCT00147511
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2011-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00147511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00147511, "Time To Efficacy and Onset Of Action Of Linezolid". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00147511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*